"Den größten Behandlungsschwerpunkt am Standort Karolinen-Hospital bilden aktuell Herz-/Kreislauf- und Gefäßerkrankungen, die fachübergreifend in den Kliniken für Angiologie, Gefäßchirurgie und Kardiologie behandelt werden. Für die qualitätsgesicherte Behandlung von Tumorerkrankungen stehen das Onkologische Zentrum II sowie ein zertifiziertes Darm- und Brustzentrum zur Verfügung. Für die Versorgung von Mutter und Kind wird dank enger Kooperation von Geburtshilfe und Kinder- und Jugendmedizin (Pädiatrie), inkl. Neonatologie, ein moderner geburtshilflicher Schwerpunkt angeboten. Rund 1.600 Kinder erblicken hier jährlich das Licht der Welt."

During the past decade, Klinikum Arnsberg - Karolinen Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Arnsberg - Karolinen Hospital" #1 sponsor was "Veryan Medical Ltd." with 2 trials, followed by "Boston Scientific Corporation" with 1 trials sponsored, "InnoRa GmbH" with 1 trials sponsored, "Klinikum Arnsberg" with 1 trials sponsored and "Medtronic Endovascular" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Arnsberg - Karolinen Hospital" #1 collaborator was "Boston Scientific Corporation" with 2 trials as a collaborator, "B. Braun Melsungen AG" with 1 trials as a collaborator, "ClinLogix. LLC" with 1 trials as a collaborator, "Klinikum Arnsberg" with 1 trials as a collaborator and "Massachusetts General Hospital" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Arnsberg - Karolinen Hospital" are "Peripheral Arterial Disease" (5 trials), "Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC" (1 trials), "Atherosclerotic Disease" (1 trials), "Chronic Venous Disorder" (1 trials) and "Critical Limb Ischemia" (1 trials). Many other conditions were trialed in "Klinikum Arnsberg - Karolinen Hospital" in a lesser frequency.

Most popular intervention types in "Klinikum Arnsberg - Karolinen Hospital" are "Device" (9 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abre venous self-expanding stent system" (1 trials), "Aspirin 100mg" (1 trials), "BioMimics 3D Stent" (1 trials), "BioMimics 3D Vascular Stent System" (1 trials) and "Eluvia Vascular Stent System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Arnsberg - Karolinen Hospital" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Arnsberg - Karolinen Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Klinikum Arnsberg - Karolinen Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Arnsberg - Karolinen Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".